Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 3,214 Nurix Therapeutics, Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed Apr 30, 2026

On Apr 30, 2026, Hansen Gwenn (Chief Scientific Officer) sold 3,214 Nurix Therapeutics, Inc. shares at US$16.65 for US$53,513, leaving 120,399 shares. Filed Apr 30, 2026 (Form 4).

Sold
3,214 shares
Price
US$16.65
Value
US$53,513
Holding after
120,399 shares
Trading plan
No
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common StockOption exercise2,000117,005Direct
Apr 30, 2026Common StockOption exercise3,750120,755Direct
Apr 30, 2026Common StockOption exercise2,858123,613Direct
Apr 30, 2026Common StockSale3,214US$16.65120,399Direct

Source

View original at SEC

Related